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A report on the 68th Symposium on Quantitative Biology,
‘The Genome of Homo Sapiens’, Cold Spring Harbor, USA,
28 May - 2 June 2003.
The 68th Cold Spring Harbor Symposium was a celebration
of the completion of sequencing the euchromatic portions of
the human genome. There are still some gaps (around 1% of
the genome), for example in the regions of recent duplica-
tions that are a characteristic feature of the human genome
as discussed by many speakers, including Francis Collins
(National Institute of Human Genome Research, National
Institutes of Health (NIH), Bethesda, USA), Jane Rogers
(Wellcome Trust Sanger Institute, Hinxton, UK), Robert
Waterston (University of Washington, St Louis, USA) and
David Page (Howard Hughes Medical Institute and White-
head Institute, Cambridge, USA); more details of their talks
are discussed later. This creates pleasing opportunities for
more celebrations in the future as the ‘true’ completion is
asymptotically achieved. In general, however, the current
sequence is a (nearly) complete and accurate representation
of the human genome and the time is ripe for a thorough
genome analysis. 
Big open questions remain. To mention just the obvious ones,
how many protein-coding and RNA-coding genes are there in
the human genome and other genomes, and how many
pseudogenes; what is the extent of alternative splicing, and
how important are antisense RNAs? In one answer to a long-
standing question, the winner of the notorious bet on the
number of human protein-coding genes has been announced:
Lee Rowen (Institute for Systems Biology, Seattle, USA), who
placed her wager on around 25,000 genes. Nevertheless, new
genes keep emerging through computational and experimen-
tal analyses, and the important question remains: are there
many genes in the genome that are expressed only for a short
time and in specialized tissues, and so do not show up in EST
libraries, and that are poorly conserved in evolution and so
are not readily detectable in database searches? 
The answers to these and other, even more fundamental,
open questions are to be sought in evolutionary genomics.
This simple concept has won over the mainstream genomics
community, as this year’s Symposium showed with crystal
clarity. The recognition is probably data-driven: with the
completion of the advanced draft of the mouse genome, the
rapid progress in sequencing the rat and chimpanzee
genomes, and a considerable amount of sequencing of other
mammalian genomes, mammalian comparative genomics
can now be pursued in earnest. Discussion of genome com-
parison methods and results dominated half of the presenta-
tions at the Symposium, if not more. Issues that, just two or
three years ago, would have been considered arcana of evo-
lutionary biology - such as the use of the Ka/Ks ratio (the
ratio of the rate of non-synonymous nucleotide substitu-
tions, which lead to a change in the encoded amino acid, to
the rate of synonymous ones) to distinguish between purify-
ing and positive selection - were addressed in many talks
and vigorously debated. Purifying selection is selection
acting against deleterious mutations, which are eliminated
from the population. This is by far the predominant form of
selection operating in evolution, the result being the largely
neutral character of molecular evolution and preservation of
the status quo in terms of fitness. A small minority of muta-
tions significantly increases the relative fitness of their carri-
ers, however. The frequency of these beneficial alleles
increases and, ultimately, they are fixed in the population by
positive selection.
A number of fundamental evolutionary issues were raised at
the symposium. For example, what fraction of nucleotides in
the human genome is constrained by purifying selection;
this was discussed, in particular, by Collins, David Haussler
(University of California-Santa Cruz, USA), and Ross Hardi-
son (Pennsylvania State University, University Park, USA).The prevailing view, reported in the mouse genome publica-
tion and largely agreed with by all three speakers, seems to
be that, of the around 40% of nucleotides in the human
genome that could be aligned with counterparts in the
mouse genome, about 5% are conserved as a result of selec-
tion, whereas the remaining 35% simply have not had time
to change. To phrase it somewhat differently, 95% of our
DNA seems to be ‘junk’. The margins of error on these
numbers seem to be quite large, however. Firstly, delin-
eation of short conserved ‘islands’ in long stretches of non-
coding sequence is far from straightforward, and the
approximately 40% value for sequence conservation might
require revision, most likely downward. Secondly, the frac-
tion of nucleotides conserved simply because of insufficient
time for divergence obviously depends on the rate of neutral
substitutions. The current best ‘guesstimate’ for human and
mouse is a Ks value of around 0.6 substitutions per site,
which means that the great majority of the conserved
nucleotides have nothing to do with selection. This value
depends on alignment procedures and statistical models of
sequence evolution, however, and these are currently far
from perfect. Again a revision might be due, most likely
upwards. Should it be concluded that the human and mouse
sequences are actually saturated with respect to neutral
substitutions, any observed sequence conservation will have
to be attributed to purifying selection. 
Thus, we really do not know what fraction of our genome is
subject to selection and hence, presumably, is functionally
important. We are reasonably sure about the approximately
1.5% of the genome that consists of protein- and RNA-coding
sequences: with the exception of the positions of synonymous
substitutions, the great majority of these sequences -
amounting to around 1% of the genome - are indeed under
purifying selection. Of course, there are also some important
stretches among non-coding sequences, such as transcrip-
tional promoters and enhancers. The uncertainty about the
amount of functionally constrained non-coding sequence is
huge, however, ranging from perhaps as little as 2% of the
genome to as much as 20%. Knowing the true extent of
selective constraint in the genome is important not only
from a purely theoretical standpoint, but for the practical
task of identifying non-coding functional elements in the
genome or, perhaps, in part, sequences coding for unknown
forms of RNA. Although it is our impression that the uncer-
tainty in the estimates of the fraction of the genome that is
subject to selection was not fully exposed at the Symposium,
at least one crucial aspect of the solution was stressed
repeatedly: sequences, sequences, and more sequences will
be the key. Indeed, comparison of genome sequences that
are definitely far from saturation (for example human
against chimpanzee) and saturated ones (for example
human against monotreme) will help us reach certainty.
Another part of the solution is, undoubtedly, a better theory
that would allow us to estimate the Ks value. 
Positive (Darwinian) selection at the molecular level appears
to be rare but is critical for adaptation and for the ‘invention’
of new functions. These innovations are likely to be crucial
for speciation, including the origin of modern humans.
Detection of positive selection is far from being straightfor-
ward, however, as emphasized in several presentations at
the Symposium and the ensuing discussions. Positive selec-
tion is measured by comparing the rate of non-synonymous
to the rate of synonymous mutations in protein-coding
sequences. Most often, the actual value determined is the
Ka/Ks ratio: Ka/Ks >1 is taken as evidence of positive selec-
tion, whereas the much more common case of Ka/Ks < <1
reflects strong purifying selection. Yoshiyuki Sakaki (RIKEN
Genomic Science Center, Yokohama, Japan) presented one
of the first large-scale sequence comparisons of human and
chimpanzee genes, which yielded a surprisingly large
number of pairs with Ka/Ks > 1. During the discussion,
however, Ewan Birney (European Bioinformatics Institute,
UK) suggested that many, if not most, of these are likely to be
statistical fluctuations exacerbated by the small number of
nucleotide substitutions (typically, human and chimp genes
are approximately 98% identical). It seems that, without a
robust statistical analysis, Ka/Ks values for closely related
genomes could be more misleading than illuminating. In
fact, it has been shown previously that tests for selection
developed for large samples tend to be too liberal when
applied to small samples. A small-sample test has been
developed and might be a more reliable alternative.
Andy Clark (Cornell University, Ithaca, USA) discussed
elegant maximum-likelihood approaches for testing the
human-chimp comparisons for neutrality and accelerated
substitution rate. Application of these methods to numerous
alignments produced with chimp sequences from Celera
Genomics yielded a list of candidates for positively selected
human genes, which seemed to be plausible from the biologi-
cal standpoint and compatible with the results from other
studies - the list includes for example, some olfactory receptor
genes and a number of genes involved in immunity and repro-
duction. 
A true highlight of the Symposium was the presentation by
Svante Pääbo (Max Planck Institute for Evolutionary
Anthropology, Leipzig, Germany) who also described a com-
parative-genomic study, in this case, of large random
samples of the olfactory receptor genes sets from humans,
great apes, several species of monkeys, and non-primate
mammals. Pääbo and coworkers discovered two dramatic
phases of pseudogenization of the olfactory receptor genes:
the first occurred early in the evolution of monkeys, whereas
the second took place after the divergence of the human
lineage from that of chimpanzee and might still be ongoing
in humans. Strikingly, the first wave of pseudogenization of
olfactory receptor genes showed a perfect correlation with
the advent of full trichromatic vision: once you see the world
in color, smelling it precisely seems to be less of an issue. It
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Genome Biology 2003, 4:331was also suggested during the discussion that the second
wave might have been linked to the increasing crowding of
human populations, as a result of which smelling one’s
neighbor too keenly could be a disadvantage, but the true
cause remains to be understood. This study was met with
considerable interest and even enthusiasm, perhaps as a
glimpse of things to come with the dawn of genuine biologi-
cal understanding of genomics. 
In conclusion, genomics is going comparative in earnest. The
importance of robust theory for further success of evolution-
ary genomics cannot be overemphasized. Many ready-made
solutions can be found in the annals of molecular evolution
and population genetics but there is no doubt that new con-
cepts and methods will also emerge.
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